MACKENZIE WALSER has a total of 19 patent applications. Its first patent ever was published in 1973. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, foods and drinks and organic fine chemistry are RECEPTOR HOLDINGS INC, SENTAN PHARMA INC and QIN XUEFANG.
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Organic fine chemistry | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Foods | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Unspecified technologies | |
#6 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Walser Mackenzie | 12 |
#2 | Makenjii Warusaa | 2 |
#3 | Walser Mackenzie Dr | 1 |
#4 | Walser H | 1 |
Publication | Filing date | Title |
---|---|---|
WO9934813A1 | Supplement for dialysis patients | |
AU5813598A | Supplement for dialysis patients | |
WO9306726A1 | Methods for treatment of free-radical-mediated tissue injury | |
CA1023664A | Composition and method for promotion of protein synthesis and suppression of urea formation in the body utilizing alpha-hydroxy-acid analogs of amino acids | |
AU5794173A | Composition and method for promotion of protein synthesis and suppression of urea formation inthe body |